• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10604
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/05/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device is a combination product.
 
Event or Problem Description
It was reported that the stent was explanted.The target lesion was located in the left anterior descending artery.A 2.50 x 24mm synergy drug-eluting stent was implanted for treatment.However, a non-bsc guide wire became entangled with the newly placed stent and when trying to retract the wire, the stent dislodged from the coronary artery and stayed on the wire until the wire was retracted to the femoral artery.The physician was able to retrieve the deployed stent out with a snare.No further patient complications were reported.
 
Event or Problem Description
It was reported that the stent was explanted.The target lesion was located in the left anterior descending artery.A 2.50 x 24mm synergy drug-eluting stent was implanted for treatment.However, a non-bsc guide wire became entangled with the newly placed stent and when trying to retract the wire, the stent dislodged from the coronary artery and stayed on the wire until the wire was retracted to the femoral artery.The physician was able to retrieve the deployed stent out with a snare.No further patient complications were reported.
 
Additional Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: synergy ii us mr 2.50 x 24mm stent was returned for analysis.The stent was noted to be expanded and damaged.The stent delivery system was not reurned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10214451
Report Number2134265-2020-07987
Device Sequence Number2133923
Product Code NIQ
UDI-Device Identifier08714729840213
UDI-Public08714729840213
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/02/2022
Device Model Number10604
Device Catalogue Number10604
Device Lot Number0025215885
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/24/2020
Initial Date Received by Manufacturer 06/08/2020
Supplement Date Received by Manufacturer07/22/2020
Initial Report FDA Received Date06/30/2020
Supplement Report FDA Received Date08/12/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDEWIRE: BMW; GUIDEWIRE: BMW; GUIDEWIRE: BMW
Outcome Attributed to Adverse Event Required Intervention;
-
-